SVA vs GILD: Which Stock is Better?
Side-by-side comparison of Sinovac Biotech Ltd and Gilead Sciences Inc in 2026
SVA
Sinovac Biotech Ltd
$6.47
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | SVA | GILD | Winner |
|---|---|---|---|
| Market Cap | $642.44M | $170.84B | GILD |
| P/E Ratio | 6.66 | 20.27 | SVA |
| EPS (TTM) | $0.97 | $6.79 | GILD |
| Revenue Growth | 3.0% | 0.0% | SVA |
| Gross Margin | 86.8% | 78.8% | SVA |
Analyze SVA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVA or GILD a better investment?
Comparing SVA and GILD: Sinovac Biotech Ltd has a market cap of $642.44M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVA and GILD?
SVA (Sinovac Biotech Ltd) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVA or GILD?
Based on P/E ratios, SVA trades at a lower multiple (6.7x vs 20.3x).
Which is growing faster: SVA or GILD?
SVA has higher revenue growth at 3.0% vs 0.0% for GILD.
Which company is more profitable: SVA or GILD?
Sinovac Biotech Ltd (SVA) has higher gross margins at 86.8% compared to 78.8% for GILD.
Which is the larger company: SVA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $642.44M for SVA.
Should I buy SVA or GILD in 2026?
Both SVA and GILD have investment merit. SVA trades at $6.47 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVA and GILD stock?
Key differences: Market Cap ($642.44M vs $170.84B), P/E Ratio (6.7x vs 20.3x), Revenue Growth (3.0% vs 0.0%), Gross Margin (86.8% vs 78.8%).